Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CDV3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SNRPA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VIMP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CADM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGFBP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PALD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF134 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SEC61B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIAS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AQR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFT57 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRRC2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITGA8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AGAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCR10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STAT3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD18A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LPCAT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on